bd 1047 has been researched along with scopolamine hydrobromide in 1 studies
| Studies (bd 1047) | Trials (bd 1047) | Recent Studies (post-2010) (bd 1047) | Studies (scopolamine hydrobromide) | Trials (scopolamine hydrobromide) | Recent Studies (post-2010) (scopolamine hydrobromide) |
|---|---|---|---|---|---|
| 118 | 0 | 54 | 7,548 | 563 | 1,401 |
| Protein | Taxonomy | bd 1047 (IC50) | scopolamine hydrobromide (IC50) |
|---|---|---|---|
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.003 | |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 0.006 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.0006 | |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.0026 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alkam, T; Espallergues, J; Keller, E; Maurice, T; Nabeshima, T; Nitta, A; Vamvakides, A; Villard, V; Yamada, K | 1 |
1 other study(ies) available for bd 1047 and scopolamine hydrobromide
| Article | Year |
|---|---|
Antiamnesic and neuroprotective effects of the aminotetrahydrofuran derivative ANAVEX1-41 against amyloid beta(25-35)-induced toxicity in mice.
Topics: Amyloid beta-Peptides; Animals; Avoidance Learning; Brain; Caspase 3; Caspase 9; Cell Death; Ethylenediamines; Furans; Glial Fibrillary Acidic Protein; Hippocampus; Learning Disabilities; Lipid Peroxidation; Male; Memory; Memory Disorders; Mice; Muscarinic Antagonists; Neuroimmunomodulation; Neuroprotective Agents; Oxidative Stress; Peptide Fragments; Scopolamine; Space Perception | 2009 |